Home » Topics » BioWorld Science

BioWorld Science
RSS

DRD2 rs18000497 polymorphism is a pharmacogenetic marker in schizophrenia patients on haloperidol

Oct. 15, 2021

CT-7439: a potential first-in-class oral cyclin K glue degrader

Oct. 15, 2021

Knocking down Snai1 rescues right ventricular failure in rats by blockade of EtM transition

Oct. 15, 2021

Liver sequencing gives insight into alcoholic, nonalcoholic disease

Oct. 15, 2021

Preclinical studies show potential of melanocortin agonists PL-8331 and PL-9654 for ocular diseases

Oct. 14, 2021

Immusoft and Takeda to jointly develop cell therapies for neurometabolic disorders

Oct. 14, 2021

Titan Pharmaceuticals and MUSC enter research agreement on kappa-opioid receptor agonists

Oct. 14, 2021

SparingVision and Intellia Therapeutics establish strategic collaboration for ocular diseases

Oct. 14, 2021

BNIP3L is a molecular target in mitophagy defects and mitochondrial dysfunction

Oct. 14, 2021

Ikena Oncology targets TEAD transcription in cancer with IK-930

Oct. 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...